September 30, 2016 11:19 AM EDT

Week in review: Clinton over Trump; the hubs have it; we'll always have Paris

Endpoints Premium

This article is available only to Premium subscribers

Upgrade to Premium for unlimited access and Premium exclusives.

UPGRADE LOG IN

TRENDING NOW

Who pays the most in biopharma? We analyzed median pay at 177 companies

FDA publishes repository of 200+ drug rejection letters, promising more in the future

Biotech’s Q2 numbers paint a picture of the good, the bad and the ugly

AbbVie inks $700M deal with IGI for multiple myeloma trispecific antibody

Kidney health biotech emerges with $54M to follow in Vertex’s footsteps

sponsored

Uncovering the Potential of Targeting the CD38 Pathway for Immune-Mediated Diseases